Wagdy M. Eldehna
About
Wagdy M. Eldehna is a scholar working on Organic Chemistry, Molecular Biology and Oncology.
According to data from OpenAlex, Wagdy M. Eldehna has authored 262 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Organic Chemistry, 159 papers in Molecular Biology and 39 papers in Oncology. Recurrent topics in Wagdy M. Eldehna's work include Synthesis and biological activity (91 papers), Enzyme function and inhibition (68 papers) and Synthesis and Catalytic Reactions (52 papers). Wagdy M. Eldehna is often cited by papers focused on Synthesis and biological activity (91 papers), Enzyme function and inhibition (68 papers) and Synthesis and Catalytic Reactions (52 papers). Wagdy M. Eldehna collaborates with scholars based in Egypt, Saudi Arabia and Italy. Wagdy M. Eldehna's co-authors include Hatem A. Abdel‐Aziz, Claudiu T. Supuran, Sara T. Al‐Rashood, Tarfah Al‐Warhi, Alessio Nocentini, Sahar M. Abou‐Seri, Eslam B. Elkaeed, Hazem A. Ghabbour, Hany S. Ibrahim and Mahmoud A. El Hassab and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
In The Last Decade
Wagdy M. Eldehna
253 papers receiving 7.3k citations
Peers
Wagdy M. Eldehna
Ibrahim H. Eissa Egypt
Hatem A. Abdel‐Aziz Egypt
Ähmed Kamal India
Ahmed M. Metwaly Egypt
Chunquan Sheng China
Susan L. Morris‐Natschke United States
Harun Patel India
Michael Gütschow Germany
Jinyi Xu China
Hong‐Min Liu China
Citations per year, relative to Wagdy M. Eldehna Wagdy M. Eldehna (= 1×)
peers
Ibrahim H. Eissa
Countries citing papers authored by Wagdy M. Eldehna
Since
Specialization
Citations
This map shows the geographic impact of Wagdy M. Eldehna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wagdy M. Eldehna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wagdy M. Eldehna more than expected).
Fields of papers citing papers by Wagdy M. Eldehna
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Wagdy M. Eldehna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wagdy M. Eldehna. The network helps show where Wagdy M. Eldehna may publish in the future.
Co-authorship network of co-authors of Wagdy M. Eldehna
This figure shows the co-authorship network connecting the top 25 collaborators of Wagdy M. Eldehna. A scholar is included among the top collaborators of Wagdy M. Eldehna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wagdy M. Eldehna. Wagdy M. Eldehna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Abdel‐Aziz, Hatem A., et al.. (2025). DprE1 inhibitors: An insight into the recent developments and synthetic approaches. European Journal of Pharmaceutical Sciences. 209. 107062–107062.
2.
Batran, Rasha Z., Ninh The Son, Yusuke Kasai, et al.. (2025). Synthesis and mechanistic insights of Coumarinyl-Indolinone hybrids as potent inhibitors of Leishmania major. European Journal of Medicinal Chemistry. 288. 117392–117392.
3.
Elgammal, Walid E., Hazem Elkady, Reda G. Yousef, et al.. (2025). New nicotinamide–thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluation. RSC Advances. 15(18). 14477–14498.
4.
Almehizia, Abdulrahman A., Ahmed M. Naglah, Mohammed H. Alqarni, et al.. (2025). Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents. RSC Advances. 15(46). 39161–39179.
5.
Khaleel, Eman F., Abdel‐Razik H. Abdel‐Razik, Ninh The Son, et al.. (2025). Discovery of N′-(1-(coumarin-3-yl)ethylidene)benzenesulfonohydrazide as a novel wound healing enhancer: synthesis, biological assessment, and molecular modeling. Frontiers in Chemistry. 13. 1621717–1621717.
6.
Al‐Rashood, Sara T., et al.. (2024). Novel imidazo[2,1-b]thiazoles and imidazo[1,2-a]pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: Design, synthesis and biological evaluations. Bioorganic Chemistry. 151. 107644–107644.
7.
El‐Moselhy, Tarek F., Eman A. El-Bastawissy, Rehab Mustafa Badi, et al.. (2024). Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities. Bioorganic Chemistry. 143. 107101–107101.
8.
Abdulla, Maha‐Hamadien, Zainab M. Elsayed, Moataz A. Shaldam, et al.. (2024). Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments. Bioorganic Chemistry. 151. 107626–107626.
9.
Gaber, Ahmed A. Abdel, Ayman Abo Elmaaty, Marwa Sharaky, et al.. (2024). Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction. Bioorganic Chemistry. 145. 107223–107223.
10.
Eldehna, Wagdy M., Zainab M. Elsayed, Mahmoud A. El Hassab, et al.. (2024). Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors. International Journal of Biological Macromolecules. 279(Pt 2). 135010–135010.
11.
Salem, Rofaida, et al.. (2024). Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-α-mediated inflammation. International Journal of Biological Macromolecules. 283(Pt 2). 137554–137554.
12.
Shaldam, Moataz A., Maha‐Hamadien Abdulla, Andrea Angeli, et al.. (2024). Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations. Journal of Molecular Structure. 1309. 138148–138148.
13.
Eldehna, Wagdy M., Alessio Nocentini, Alessandro Bonardi, et al.. (2023). 4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments. European Journal of Medicinal Chemistry. 250. 115180–115180.
14.
Sheta, Eman, Hanan S. El‐Abhar, Dalaal M. Abdallah, et al.. (2023). Morin suppresses mTORc1/IRE-1α/JNK and IP3R-VDAC-1 pathways: Crucial mechanisms in apoptosis and mitophagy inhibition in experimental Huntington's disease, supported by in silico molecular docking simulations. Life Sciences. 338. 122362–122362.
15.
Shaldam, Moataz A., Radwan El‐Haggar, Taghreed A. Majrashi, et al.. (2023). 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 258. 115610–115610.
16.
Eissa, Noura G., Wagdy M. Eldehna, Mahmoud A. El Hassab, et al.. (2023). Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure. International Journal of Pharmaceutics. 642. 123161–123161.
17.
El-Bastawissy, Eman A., Eman F. Khaleel, Rehab Mustafa Badi, et al.. (2023). Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights. Bioorganic Chemistry. 140. 106799–106799.
18.
Majrashi, Taghreed A., et al.. (2023). An updated review of fatty acid residue-tethered heterocyclic compounds: synthetic strategies and biological significance. RSC Advances. 13(20). 13655–13682.
19.
Al‐Warhi, Tarfah, et al.. (2023). Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis. Archiv der Pharmazie. 357(2). e2300529–e2300529.
20.
Farès, Mohamed, Wagdy M. Eldehna, Sahar M. Abou‐Seri, et al.. (2015). Design, Synthesis and In Vitro Antiproliferative Activity of Novel Isatin‐Quinazoline Hybrids. Archiv der Pharmazie. 348(2). 144–154.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ibrahim H. Eissa Breakdown of academic impact, for papers by Hatem A. Abdel‐Aziz Breakdown of academic impact, for papers by Ähmed Kamal Breakdown of academic impact, for papers by Ahmed M. Metwaly Breakdown of academic impact, for papers by Chunquan Sheng Breakdown of academic impact, for papers by Susan L. Morris‐Natschke Breakdown of academic impact, for papers by Harun Patel Breakdown of academic impact, for papers by Michael Gütschow Breakdown of academic impact, for papers by Jinyi Xu Breakdown of academic impact, for papers by Hong‐Min Liu